2018
DOI: 10.14712/23362936.2018.8
|View full text |Cite
|
Sign up to set email alerts
|

Olfaction and Colour Vision: What Can They Tell Us about Parkinson’s Disease?

Abstract: Parkinson’s disease is a neurodegenerative disorder with the pathological accumulation of alpha synuclein in the brain and peripheral nerve tissue. Early stages of synucleinopathies, often present clinically with rapid eye movement (REM) sleep disorder (RBD). Clinical markers that indicate early progression from RBD to manifest synucleinopathies include abnormal dopamine transporter (DAT) imaging, motor and non-motor symptoms. Despite the high diagnostic strength of DAT imaging and motor abnormalities, they ar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…Olfactory dysfunction has been incorporated both in Movement Disorder Society clinical diagnostic criteria for PD and research criteria for prodromal PD, demonstrating its role in the diagnosis and prediction of PD (5)(6)(7). PD-associated smell dysfunction involves several domains of odor perception, i.e., detection threshold, identification, discrimination, and memory (8)(9)(10). The structural changes in the olfactory bulb, neurotransmitter system dysfunction, and inflammatory activity in the brain are all possible mechanisms of olfactory impairment in PD (11).…”
Section: Introductionmentioning
confidence: 99%
“…Olfactory dysfunction has been incorporated both in Movement Disorder Society clinical diagnostic criteria for PD and research criteria for prodromal PD, demonstrating its role in the diagnosis and prediction of PD (5)(6)(7). PD-associated smell dysfunction involves several domains of odor perception, i.e., detection threshold, identification, discrimination, and memory (8)(9)(10). The structural changes in the olfactory bulb, neurotransmitter system dysfunction, and inflammatory activity in the brain are all possible mechanisms of olfactory impairment in PD (11).…”
Section: Introductionmentioning
confidence: 99%
“…The clinical prevalence of hyposmia is as high as 90% and can manifest 20 years prior to diagnosis [ 197 ]. In the current review, olfactory dysfunction mimicking clinical observations was identified in just under half of PD mouse models, with 4 of them showing inconsistent findings.…”
Section: Discussionmentioning
confidence: 99%